Applicability of biomarkers in ischemic stroke.

Applicability of biomarkers in ischemic stroke. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Applicability of biomarkers in ischemic stroke. Abstract Text:

Mar Castellanos, Serena,Mar Castellanos, Serena,

Cerebral ischemia results in the activation of a cascade of molecular events as a result of which several substances with the potential characteristics of biomarkers are released into the peripheral blood. Although still in the research phase, the analysis of these biomarkers in the serum has proved to be useful for stroke diagnosis, as well as for the prediction of the evolution of the ischemic lesion and the clinical prognosis. In fact, the feasibility and applicability of a panel of biomarkers for the diagnosis of stroke has recently been tested. Biomarkers of excitotoxicity, inflammation and oxidative stress have been demonstrated as being useful in the prediction of ischemic lesion enlargement and secondary neurological deterioration. On the other hand, biomarkers of endothelial damage have been shown to be especially helpful in the prediction of hemorrhagic transformation of the ischemic lesion, both spontaneously and after the administration of thrombolytic therapy, as well as in the prediction of brain edema with the secondary development of malignant middle-cerebral-artery infarction. Moreover, coagulation and fibrinolytic-cascade markers have been reported as being correlated with the recanalization rate after the administration of thrombolysis, and they might therefore be useful in estimating the effectiveness of thrombolytic therapy. However, for these biomarkers to become applicable to routine clinical practice, faster tests to perform the analyses are required and further studies must be undertaken to validate and generalize the results.

Applicability of biomarkers in ischemic stroke. Publishing Authors By Initials

M Castellanos,J Serena,M Castellanos,J Serena,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Applicability of biomarkers in ischemic stroke. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cerebrovascular diseases (Basel, Switzerland)

VOLUME: 24 Suppl 1

Page Numbers: 7-15

Journal Abbreviation: Cerebrovasc. Dis.

ISSN: 1015-9770

DAY: 1

MONTH: 11

YEAR: 2007

Applicability of biomarkers in ischemic stroke. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9100851

Applicability of biomarkers in ischemic stroke. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Applicability of biomarkers in ischemic stroke. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Applicability of biomarkers in ischemic stroke.

AFFILIATION: Department of Neurology, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain. nrl.mcastellanos@htrueta.scs.es

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cerebrovasc Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Applicability of biomarkers in ischemic stroke Related Publications

• Applicability of biomarkers in ischemic stroke.
• OP14.11: Integrated Doppler and BPS in severe IUGR fetus predict neonatal outcome.
• OP14.13: Childhood cardiovascular compromise may be assessed in utero and soon after birth in IUGR fetuses.
• Pancreatic calcifications in cystic fibrosis (CF).
• [65 autotransplants in burned patients]
• [Care that only wants to soothe]
• [Health for all: talking about it and doing it. . .]
• [How is the foreign personnel in the Tessin getting along?]
• [Our journal in science citation index.]
• [Palliative care: a chance in medicine?]
• [Reflections on the symposion on the 26 and 27 April of this year at the congress center in Lugano: Organ transplantation: honors and conflicts]
• [The adrenal factor in bronze diabetes.]
• [The spanish journal of nuclear medicine in 2007. Balance.]
• [Under the banner of collaboration]